Omnes Capital's investments
Founded in 1989 by Denis Akriche, armatis-lc is a leading contact centre and call centre operator in France. armatis-lc, a leading player in the contact centre market in France, boasts 20 years’ experience and has focused on four areas: a full customer experience, a virtuous cycle of data use, international geographical coverage and a strong reputation for social responsibility.
Progexia is an alternative operator serving private health insurance companies, wich provide solutions in the Cloud for reduce benefits payments costs.
Mirabeau is a group formed of two SMEs specialised in building security.
Comtra designs, manufactures and distributes natural smoke extraction and aeration products. Unitecnic designs, manufactures and distributes access control products, harnessing RFID technology in particular. Thanks to its multidisciplinary research office (mechanics, electronics and networking), the Mirabeau group possesses patents and innovative solutions at the cutting edge of its markets. Its customers are professional distributors, joiners, locksmiths, installation contractors and façade specialists. Comtra and Unitecnic work on a number of flagship construction projects (head offices,
museums, hospitals, stadia, etc.).
Pixium Vision was founded in December 2011 by Bernard Gilly, Professor José-Alain Sahel, and several highly renowned scientists from prestigious academic and technology institutions. The company develops innovative vision restoration systems (VRS) that are active medical devices. They can be implanted to treat blindness caused by degeneration of the photo-receptor cells of the retina. VRS stimulate the retina to produce a bionic vision and aim to significantly improve the independence, mobility and quality of life of patients who have lost their sight. Called IRIS® (in clinical trials) and PRIMA (under development), these VRS harness the latest advances in microelectronics/nanoelectronics, optronics, neurobiology and software. With the help of these technologies, Pixium Vision ultimately aims to provide a therapeutic solution delivering bionic vision as close as possible to normal vision.
A long-term view
Alexia Perouse (Partner at Omnes Capital) and Bernard Gilly first discussed vision restoration systems in the early 2000s. "VRSs aim to enable blind people to perceive shapes and movements, a really tremendous project. But their design came up against two hurdles, systems miniaturisation and real-time image transmission", explains Bernard Gilly.
Pixium overcame these hurdles in 2011 when it launched IRIS (short for Intelligent Retinal Implant System), consisting of a pair of glasses with an integrated mini-camera linked to a pocket computer and a retinal implant that stimulates the brain cells.
"It met all our criteria for investment: disruptive technology, a seasoned management team and a promising medtech sector", says Alexia Perouse. So in 2012, Omnes Capital invested €5 million.